OneBreath™ by Breath Diagnostics: The Simply Superior Breath Analysis Solution

OneBreath™ by Breath Diagnostics is a non-invasive breath analysis that uses a unique microreactor for quick UHPLC-MS analysis, setting a new standard for breath diagnostics.

0:00
0:00
https://res.cloudinary.com/breath-diagnostics/video/upload/v1739889328/The_Science_Behind_Breath_Diagnostics_Blog_Post_pu3g7t.mp3

Breath analysis has long held the promise of revolutionizing diagnostics, particularly in detecting diseases like lung cancer through non-invasive means. However, despite decades of research, traditional breath analysis has struggled to gain widespread clinical adoption. The core issue? A lack of standardization in sampling, pre-concentration, and analysis methods.

Enter OneBreath™ by Breath Diagnostics (BDx)—a game-changing technology that overcomes the pitfalls of traditional breath analysis while providing unparalleled accuracy, reliability, and ease of use. Let’s explore why OneBreath™ is simply superior to other breath analysis methods.

The Challenges of Traditional Breath Analysis

Before we dive into OneBreath™’s innovation, let’s look at the shortcomings of traditional breath analysis:

1. Lack of Standardization in Sampling

Breath composition varies significantly based on how it is collected. Traditional methods distinguish between:

  • End-tidal breath (deep lung air)
  • Late expiratory breath (includes upper airways)
  • Mixed expiratory breath (a blend of lung and oral cavity air)

These variations introduce inconsistencies in biomarker concentration measurements, making it difficult to establish reliable diagnostic thresholds.

2. Pre-Concentration Problems

Breath biomarkers exist in extremely low concentrations, requiring pre-concentration techniques before analysis. Traditional methods rely on sorbent tubes, such as:

  • Thermal desorption tubes
  • Solid-phase microextraction (SPME)
  • Needle trap devices (NTDs)

These methods introduce contamination risks and sample degradation, leading to inconsistent and unreliable results.

3. Inefficiencies in Ionization and Analysis

Gas chromatography-mass spectrometry (GC-MS) remains the gold standard for breath biomarker validation, but it has limitations:

  • Thermal degradation risk due to heating during desorption
  • Loss of VOCs during transfer
  • Inconsistent ionization efficiency
  • Extremely slow analysis times—GC-MS takes up to an hour per sample

These drawbacks have hindered traditional breath analysis from becoming a routine diagnostic tool.

How OneBreath™ is Simply Superior

OneBreath™ completely redefines breath analysis by addressing these long-standing challenges. With a patented microreactor technology, it enables a more efficient, standardized, and accurate diagnostic process.

1. Standardization Through One Exhale

OneBreath™ streamlines sampling by requiring just one exhale into a Tedlar® bag. This single-breath approach ensures that every sample contains a standardized concentration of volatile organic compounds (VOCs), solving a major issue in breath diagnostics.

Eliminates variability in sampling

  • Ensures precise biomarker concentration measurements
  • Enhances reproducibility and clinical reliability

With OneBreath™, we no longer need to worry about sampling inconsistencies—it’s a single, controlled breath every time.

2. Smart VOC Capturing with a Novel Microreactor

Instead of relying on traditional adsorption-based trapping, where VOCs are physically stuck onto surfaces and later released by heating (which can cause sample degradation), OneBreath™ chemically derivatizes VOCs into adducts.

Why is this better? The microreactor forms stable cationic adducts, which are chemically bound rather than physically trapped. This:

  • Prevents sample loss
  • Reduces contamination risks
  • Improves measurement sensitivity

3. Breakthrough Ionization for Ultra-Sensitive Analysis

Unlike GC-MS, which requires thermal desorption, OneBreath™’s microreactor method enhances ionization efficiency, making analysis both easier and more reliable.

Traditional VOC trapping (Desorption Tubes):

  • VOCs are physically adsorbed and require heating to be released
  • Heating can cause fragmentation and loss of biomarkers
  • Requires additional sample preparation steps

OneBreath™ Technology (BDx Derivatization):

  • VOCs form stable cationic adducts instead of being adsorbed
  • These adducts are already ionized, making mass spectrometry analysis far more sensitive and accurate
  • Cold solvent rinsing (not heat) releases VOCs, eliminating concerns over thermal degradation

4. The Ultimate Analytical Advantage: No Thermal Desorption Required

OneBreath™ uses UHPLC-MS (Ultra-High-Performance Liquid Chromatography-Mass Spectrometry) for biomarker detection, offering significant advantages:

  • No thermal degradation – samples remain intact
  • No additional sample preparation needed – no complex desorption steps
  • All adducts are positively charged – ensures consistent and efficient ionization

5. Commercial Throughput: OneBreath™ is 10x Faster

One of the biggest challenges in traditional breath analysis is processing time. Traditional methods are slow and inefficient, making high-volume testing commercially unfeasible.

Traditional Analysis: Slow and Inefficient

  • GC-MS analysis can take upwards of 1 hour per sample
  • Patient sampling with desorption tubes takes 15–30 minutes
  • Throughput is low, making large-scale implementation impractical

OneBreath™: Built for Speed and Scalability

  • UHPLC-MS analysis takes less than 10 minutes per sample
  • Patient sampling takes only 30 seconds
  • Enables high-throughput diagnostics, making breath analysis commercially viable

What does this mean? OneBreath™ is significantly faster and more feasible for real-world applications, making it the first truly scalable breath analysis technology.

The Future of Breath Analysis is Here

With OneBreath™, Breath Diagnostics has transformed a major industry challenge into its biggest strength. By tackling standardization, sample integrity, and ionization efficiency, OneBreath™ makes breath analysis:

  • More reliable – Controlled, standardized sampling eliminates errors
  • More accurate – Derivatization ensures ultra-sensitive biomarker detection
  • More efficient – No need for complex sample preparation or thermal desorption
  • 10x Faster – Ultra-fast sampling and analysis enable real-world implementation

Traditional breath analysis has struggled with consistency and practicality—but with OneBreath™, the future of breath diagnostics is now a reality.

Ready to see the future of non-invasive diagnostics? Stay tuned as Breath Diagnostics continues to revolutionize breath analysis technology.

Breath Diagnostics

Ready to Transform Lung Cancer Screening? Discover the Future Today.

Watch our video to learn how OneBreath™ is revolutionizing diagnostics with life-saving precision and simplicity.